Replies to post #46 on Sutura Inc. (fka SUTU)

[sayheydave]

Form 8-K for SUTURA, INC.


--------------------------------------------------------------------------------

4-Dec-2007

Entry into a Material Definitive Agreement, Other Events, Financial Statements and E



Item 1.01. Entry into a Material Definitive Agreement
To the extent required by Item 1.01 of Form 8-K, the information contained in or incorporated by reference into Item 8.01 of this Current Report is hereby incorporated by reference into this Item 1.01.




Item 8.01. Other Events
On December 3, 2007, the Registrant, Abbott Laboratories and Abbott Vascular Inc. entered into a Settlement, License and Release Agreement to settle and resolve that certain patent infringement lawsuit entitled Sutura, Inc. v. Abbott Laboratories and Perclose, Inc., Civil No. 2:06-CV-536 (TJW), brought in the United States District Court for the Eastern District of Texas. The Settlement, License and Release Agreement is filed as an exhibit to this Current Report and, upon such filing, is hereby incorporated by reference into this Item 8.01.
The Settlement License and Release Agreement provides, among other things, for a cross license of certain patents between the parties and a one time payment by Abbot Laboratories to Registrant in the amount of $23.0 million.
Section 9 - Financial Statements and Exhibits




Item 9.01 Financial Statements and Exhibits.
(a) Financial statements of business acquired.
Not applicable

(b) Pro forma financial information.

Not applicable

Exhibit Index
(c) Exhibits.

10.1 Settlement License and Release Agreement, dated November 21, 2007.

99.1 Press release.